erlotinib 150 mg – inhibidor oral de EGFR en cáncer de pulmón de células no pequeñas?

Primary tabs

Time ReferrerUserOperations
08/27/2025 - 00:45node/7711/trackAnonymous (not verified)details
08/26/2025 - 23:41node/7711/trackAnonymous (not verified)details
08/26/2025 - 23:40node/7711/trackAnonymous (not verified)details
08/26/2025 - 16:38node/7711/trackAnonymous (not verified)details
08/26/2025 - 12:16node/7711/trackAnonymous (not verified)details
08/26/2025 - 05:19node/7711/trackAnonymous (not verified)details
08/26/2025 - 04:46node/7711/trackAnonymous (not verified)details
08/26/2025 - 04:46node/7711/trackAnonymous (not verified)details
08/26/2025 - 04:46node/7711/trackAnonymous (not verified)details
08/26/2025 - 04:43node/7711/trackAnonymous (not verified)details
08/26/2025 - 04:21node/7711/trackAnonymous (not verified)details
08/26/2025 - 04:21node/7711/trackAnonymous (not verified)details
08/26/2025 - 02:40node/7711/trackAnonymous (not verified)details
08/26/2025 - 01:50node/7711/trackAnonymous (not verified)details
08/25/2025 - 22:15node/7711/trackAnonymous (not verified)details